Price Targets
1 Month Target: $4.50-5.00
Based on technical breakdown below recent support and continued negative sentiment post-earnings. The oversold bounce potential is limited to $6.75-7.00 resistance.
3 Month Target: $2.50-3.50
Fundamental repricing toward realistic valuation. Using normalized P/S of 5-10 (still generous for negative margin business) on annualized revenue of ~$100M gives us this range.
6 Month Target: $1.00-2.00
Full fundamental repricing as 2026 guidance execution risk materializes. If they miss their own $300-400M revenue guidance—which seems likely given Q4 execution—the stock could test cash value levels.
Conservative Scenario: $3.50 (oversold bounce then slow decline)
Baseline Scenario: $2.00 (fundamental repricing continues)
Optimistic Scenario: $1.00 (complete guidance failure and liquidity concerns)